Polpharma Overview
- Year Founded
-
1935
- Status
-
Acquired/Merged
- Employees
-
7,000
- Latest Deal Type
-
Capital Spending
- Financing Rounds
-
8
- Investments
-
7
Polpharma General Information
Description
Manufacturer of generic drugs focused on helping people to live a healthy life in a healthy world. The company manufactures prescription drugs and pharmaceuticals for in-patient care and also specializes in pharmaceutical preparations used in cardiology, gastroenterology and neurology, enabling patients healthy and long life.
Contact Information
Website
www.polpharma.pl(Operating Subsidiary)
Corporate Office
- Pelplińska 19
- Starogard Gdanski, 83-200
- Poland
Corporate Office
- Pelplińska 19
- Starogard Gdanski, 83-200
- Poland
Polpharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Polpharma Comparisons
Industry
Financing
Details
Polpharma Competitors (25)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Abbott India | Corporation | Mumbai, India | ||||
| GlaxoSmithKline Consumer Nigeria | Corporation | Lagos, Nigeria | ||||
| Adamed | Corporation | Czosnow, Poland | ||||
| Alkem Laboratories | Formerly PE-Backed | Mumbai, India | ||||
| Novartis | Corporation | Basel, Switzerland |
Polpharma Patents
Polpharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4389118-A1 | Dry powder blend pharmaceutical composition comprising ramipril and indapamide | Pending | 22-Dec-2022 | ||
| EP-4349837-A1 | A pharmaceutical intermediate | Pending | 05-Oct-2022 | ||
| EP-4295837-A1 | Ophthalmic composition comprising brimonidine | Pending | 21-Jun-2022 | ||
| EP-4289840-A1 | A process for preparing isavuconazonium sulfate | Pending | 07-Jun-2022 | ||
| EP-4279075-A1 | A pharmaceutical composition comprising elagolix | Active | 12-May-2022 | A61K9/2018 |
Polpharma Executive Team (16)
| Name | Title | Board Seat |
|---|---|---|
| Markus Sieger | Chief Executive Officer | |
| Sebastian Szymanek | President of the Management Board | |
| Wojciech Rosa | Chief Financial Officer, Corporate Finance Director & Board Member | |
| Dorota Piskorska | Chief Corporate Development Officer | |
| Bożenna Kozakiewicz | Director of Global Strategic Sourcing Department |
Polpharma Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Self | Member of the Management Board | ||
| Polpharma | Chief Financial Officer, Corporate Finance Director & Board Member |
Polpharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Polpharma Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Polpharma Investments & Acquisitions (7)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Bioeq (Zug) | 22-Dec-2017 | Pharmaceuticals | |||
| Santo Holding & Polpharma (Joint Venture) | 25-Mar-2014 | Biotechnology | |||
| Polfa Warszawa | 19-Apr-2012 | Pharmaceuticals | |||
| Akrikhin Pharmaceuticals | 28-Dec-2011 | Pharmaceuticals | |||
| Chimpharm | 20-Sep-2011 | Merger/Acquisition | Pharmaceuticals |
Polpharma Subsidiaries (2)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Akrikhin Pharmaceuticals | Pharmaceuticals | Moscow, Russia | 1936 |
| Chimpharm | Pharmaceuticals | Shymkent, Kazakhstan |
Polpharma FAQs
-
When was Polpharma founded?
Polpharma was founded in 1935.
-
Who is the CEO of Polpharma?
Markus Sieger is the CEO of Polpharma.
-
Where is Polpharma headquartered?
Polpharma is headquartered in Starogard Gdanski, Poland.
-
What is the size of Polpharma?
Polpharma has 7,000 total employees.
-
What industry is Polpharma in?
Polpharma’s primary industry is Pharmaceuticals.
-
Is Polpharma a private or public company?
Polpharma is a Private company.
-
What is Polpharma’s current revenue?
The current revenue for Polpharma is .
-
How much funding has Polpharma raised over time?
Polpharma has raised $346M.
-
Who are Polpharma’s investors?
Futurion 1 has invested in Polpharma.
-
Who are Polpharma’s competitors?
Abbott India, GlaxoSmithKline Consumer Nigeria, Adamed, Alkem Laboratories, and Novartis are some of the 25 competitors of Polpharma.
-
When was Polpharma acquired?
Polpharma was acquired on 07-May-2024.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
